Delivery Order SPE2DB24D1205-SPE2DB25FCXFE
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,238.32 by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Freestyle Lite Test Strip 50s. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-set-aside competitive award. This delivery order operates as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,543.20 to AmerisourceBergen Drug Corp for FreeStyle Lite Test Strip 50s, a diabetes monitoring medical supply. The contract, awarded on June 16, 2025, with an ultimate completion date of June 17, 2025, carries firm fixed pricing and represents a non-competitive set-aside award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency (DLA) awarded a $1,743.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for FreeStyle Lite test strips (100-count units), with performance completion by September 9, 2025. The award is unset-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $3,690.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Freestyle Lite Test Strip 50s, with an ultimate completion date of July 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $2,191.59 to AmerisourceBergen Drug Corp for Freestyle Lite Test Strips (50-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a $1,400.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Freestyle Lite test strips (50-count units). This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion and extends through December 2026. The contract was competitively awarded without set-aside provisions and will be performed at the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,261.47, is for the provision of Freestyle Lite Test Strips, a diabetes management product. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 21, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.83 to AmerisourceBergen Drug Corp for FreeStyle Lite test strips (50-count units) under a firm fixed-price contract. The award, issued on September 5, 2025, with completion targeted for September 8, 2025, represents a non-competitive delivery order without a set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.00 firm fixed-price delivery order is for the supply of 50-count boxes of Freestyle Lite test strips. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,063.02 firm fixed-price delivery order is for the provision of 4,567,920,839 Freestyle Lite Test Strips, a medical product used for diabetes management. The contract has an ultimate completion date of April 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXFEDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,437.20 by the Defense Logistics Agency (DLA) on May 30, 2025, with an ultimate completion date of June 2, 2025. The delivery order is for Freestyle Lite Test Strip 50s, a diabetes management medical supply. This award was competitively awarded without a set-aside designation and utilizes firm fixed pricing under a delivery order contract type, with performance to be executed at the company's Conshohocken location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's substantial federal contract portfolio with DLA demonstrates the company's capability to fulfill diverse medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 5/30/25 |